Tepadina recall in Canada: Defective vial seal
In plain language
This recall involves Tepadina 100 mg/vial Powder for Solution sold in Canada. It's being recalled because the vial seal and closure may be defective or loose. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot number 1709191/3.
- Contact Methapharm Inc. for return instructions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Tepadina 100 mg/vial Powder for Solution
Lot: 1709191/3
Why this matters
Defective vial seal
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 1709191/3
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Defective vial seal
What should consumers do?
Stop using the product immediately. Check the lot number 1709191/3. Contact Methapharm Inc. for return instructions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Defective vial seal
When was this product recalled?
This product was recalled on May 8, 2020.
Is the Tepadina brand affected by this recall?
Yes, Tepadina products are affected by this recall. This recall involves Tepadina 100 mg/vial Powder for Solution sold in Canada. It's being recalled because the vial seal and closure may be defective or loose. Stop using the product and follow the return steps in the official notice.